Clinical Trial Update: The Efficacy of Viburnum Opulus 3X in the Treatment of Primary Dysmenorrhea [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Viburnum opulus 3X for primary dysmenorrhea has completed. The study was sponsored by the University of Johannesburg.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysmenorrhea

Drugs mentioned

• Viburnum opulus 3X (Viburnum opulus)

Snippet

Sponsor: University of Johannesburg | Conditions: Dysmenorrhea | Phase 2 | Status: COMPLETED